Back to Case Studies

Isaac Asamoah

Director

Nutravet | October 2020

Convex Capital has acted as exclusive advisor to the Shareholder on the sale of Nutravet, Britain’s fastest growing animal healthcare company, to Swedencare AB, the market leading, listed, Swedish provider of premium animal health products to the global pet market.

The acquisition creates a unique group which entails different growth and profitability driven companies within animal health.

 

Nutravet was founded by Matthew Shaw in 2008 and is the UK’s leading exclusive-to-vet brand of premium veterinary nutraceuticals and pet supplements. The company is based in Bolton and supplies a comprehensive and unique product portfolio of nutraceuticals in the premium segment for dogs, cats and equine, which are sold exclusively to thousands of British and European veterinary clinics and animal hospitals. Nutravet will continue to be led by Matthew Shaw, who will also become one of the major shareholders of Swedencare.

The business had sales of £5.5m for the period September 2019 – August 2020.

The Convex deal team was led, managed and structured by Isaac Asamoah and Indy Singh whilst James Edge originated the transaction and identified Swedencare as a strategic acquirer.

“Convex are a shining light in the corporate finance world. They truly understand the process and their attention to detail is second to none. Quite simply, a pleasure to work with and entrepreneurs need to consider Convex as their first choice.”

Matthew Shaw, Founder

Press release: Convex completes sale of leading animal health company Nutravet.

<<Click here to read full press release>>

 

Back to Case Studies